Global Gastrointestinal Diagnostics Market Size to Exceed USD 8.23 Billion by 2035 | CAGR of 4.35%

Global Gastrointestinal Diagnostics Market Size to Exceed USD 8.23 Billion by 2035

According to a Research Report Published by Decisions Advisors & Consulting, The Global Gastrointestinal Diagnostics Market Size is expected to Grow from USD 5.15 Billion in 2024 to USD 8.23 Billion by 2035, at a CAGR of 4.35% during the forecast period 2025-2035.  

Browse 210 Market Data Tables And 45 Figures Spread Through 190 Pages and In-Depth TOC On the Global Gastrointestinal Diagnostics Market Size, Share, and COVID-19 Impact Analysis, By Test Type (Endoscopy, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin A Test, and Others), By Technology (ELISA, PCR, Microbiology, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035. Get Detailed Report Description Here: https://www.decisionsadvisors.com/reports/gastrointestinal-diagnostics-market                   

The global market for technologies, tests, and services employed to identify, monitor, and manage gastrointestinal disorders, such as infections, cancers, inflammatory bowel disease (IBD), and gastroesophageal reflux disease (GERD), is referred to as the gastrointestinal (GI) diagnostics market. This encompasses a variety of medical treatments, tests, and approaches utilised to diagnose and evaluate conditions and diseases impacting the gastrointestinal (GI) tract, which comprises the stomach, intestines, oesophagus, liver, gallbladder, and pancreas. Endoscopic ultrasound (EUS), capsule endoscopy, virtual colonoscopy, and molecular diagnostics are examples of advancements that have enhanced patient outcomes by allowing doctors to detect and diagnose GI disorders sooner. The ongoing advancement of diagnostic technologies, the growing prevalence of gastrointestinal diseases, the heightened adoption of non-invasive diagnostic techniques, and escalating healthcare expenses are all factors driving robust market growth. The market has been affected by elements like the increasing occurrence of stomach infections and cancers, along with the heightened need for point-of-care (POC) diagnostics for gastrointestinal issues. However, numerous issues, including the high cost of state-of-the-art technology, limited accessibility in resource-constrained places, regulatory barriers, and patient reluctance to invasive treatments, limit the market for gastrointestinal diagnostics.

The endoscopy segment accounted for the largest share in 2024 and is anticipated to grow at a substantial CAGR over the forecast period.       

Based on the test type, the gastrointestinal diagnostics market is divided into endoscopy, blood test, H. pylori test, calprotectin test, immunoglobulin A test, and others. Among these, the endoscopy segment accounted for the largest share in 2024 and is anticipated to grow at a substantial CAGR over the forecast period. The growing demand for non-invasive procedures, medical professionals' preference for endoscopy, and technical advancements are all contributing factors to the growth.

The PCR segment dominated the market in 2024 and is anticipated to grow at a significant CAGR during the forecast period.     

Based on the technology, the gastrointestinal diagnostics market is segmented into ELISA, PCR, microbiology, and others. Among these, the PCR segment dominated the market in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The segment's expansion is fueled by PCR's excellent sensitivity and specificity in detecting infections; it may identify a range of stomach ailments even in circumstances when traditional diagnostic methods are inadequate.

Asia Pacific is expected to hold the majority share of the global gastrointestinal diagnostics market during the forecast period.       

Asia Pacific is expected to hold the majority share of the global gastrointestinal diagnostics market during the forecast period. The market is growing as a result of improved healthcare infrastructure, more access to state-of-the-art diagnostic technology, and increased awareness of preventative healthcare. Due to government initiatives to improve healthcare access and infrastructure, as well as rising awareness of gastrointestinal health, the Chinese market for gastrointestinal diagnostics is anticipated to expand over the course of the projected period.

North America is anticipated to grow at the fastest pace in the global gastrointestinal diagnostics market during the forecast period. The launch of innovative items in the region is another crucial element of regional progress. The demand for sophisticated diagnostic solutions is being driven by the incidence of gastrointestinal disorders, such as colorectal cancer and various infections. As a result, the U.S. gastrointestinal diagnostics market is anticipated to grow significantly over the forecast period.

Major vendors in the global gastrointestinal diagnostics market are Abbott Laboratories, Beckman Coulter, Inc., bioMérieux, Bio-Rad Laboratories, Inc., DiaSorin S.p.A., EKF Diagnostics Holdings plc, F. Hoffmann-La Roche Ltd, Fujifilm Holdings Corporation, Meridian Bioscience, QIAGEN N.V., R-Biopharm AG, Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific Inc., and others.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Development   

• In July 2025, OMED Health officially introduced its new Personalised Health Plans to treat functional gastrointestinal (GI) problems, which include breath-based diagnostics, personalised medications, and clinician-led care paths.

Market Segment  

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Decisions Advisors has segmented the gastrointestinal diagnostics market based on the below-mentioned segments:  

Global Gastrointestinal Diagnostics Market, By Test Type

• Endoscopy
• Blood Test
• H. Pylori Test
• Calprotectin Test
• Immunoglobulin A Test
• Others

Global Gastrointestinal Diagnostics Market, By Technology

• ELISA
• PCR
• Microbiology
• Others

Global Gastrointestinal Diagnostics Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa